Inspire Medical Systems has appointed seasoned medical device executive Michael H. Carrel to its Board of Directors, effective July 20. Carrel has served as President, Chief Executive Officer, and a director of AtriCure since November 2012, during which time AtriCure grew from $82 million in revenue in 2013 to $535 million in 2025 while helping more than one million patients. He also served as Chairman of the Board of Directors of Axonics from 2019 through 2024, until its sale to Boston Scientific Corporation. Inspire Medical Systems is a medical technology company focused on minimally invasive solutions for obstructive sleep apnea, and its proprietary Inspire therapy is the first FDA-, EU MDR- and PDMA-approved neurostimulation technology for moderate to severe obstructive sleep apnea.
Inspire Medical Systems IncAppointment of experienced medical device executive to board strengthens governance and strategic oversight.
Boston Scientific Corp
AtriCure Inc